InsiderTrades

Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001870913-24-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-01-18 2024-01-16+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $55.29 -24.8K 907.8K -3% -$1.37M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-17 S D 10,000 $55.11 917,620 I Held by Esjay LLC — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2024-01-16 S D 5,000 $55.63 927,620 I Held by Esjay LLC — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2024-01-18 S D 9,784 $55.30 907,836 I Held by Esjay LLC — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.